John M. Evans
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $6.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 13,4211,058,784 held (−1%) | $35.13 | $471K | -26.8% |
| Jul 1SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 11,5791,047,205 held (−1%) | $35.91 | $416K | -28.4% |
| Jul 1SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 23,1001,049,105 held (−2%) | $34.26 | $791K | -25.0% |
| Jul 1SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 1,9001,047,205 held (−0%) | $34.84 | $66K | -26.2% |
| Apr 6SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 30,0781,047,205 held (−3%) | $24.58 | $739K | +4.6% |
| Apr 1SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 25,000986,667 held (−2%) | $22.37 | $559K | +14.9% |
| Apr 1SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 25,000986,667 held (−2%) | $22.76 | $569K | +12.9% |
| Feb 2SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 16,333995,334 held (−2%) | $29.19 | $477K | -12.0% |
| Feb 2SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 8,667986,667 held (−1%) | $29.74 | $258K | -13.6% |
| Feb 2SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 22,094989,573 held (−2%) | $28.27 | $625K | -9.1% |
| Feb 2SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 2,906986,667 held (−0%) | $29.00 | $84K | -11.4% |
| Oct 3SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 25,000986,667 held (−2%) | $24.51 | $613K | +4.9% |
| Oct 3SEC | BEAMBeam Therapeutics Inc. | Sell Plan | 25,000986,667 held (−2%) | $24.63 | $616K | +4.3% |
- Sell
CEO John M. Evans sold $471K of BEAM at $35.13 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO John M. Evans sold $416K of BEAM at $35.91 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO John M. Evans sold $791K of BEAM at $34.26 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO John M. Evans sold $66K of BEAM at $34.84 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO John M. Evans sold $739K of BEAM at $24.58 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO John M. Evans sold $559K of BEAM at $22.37 — pre-scheduled 10b5-1 plan sale.